$VRMMQ
Vroom, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021043465 Filed on August 11, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $761.9M $253.1M
YoY Change 201.03% -2.99%
Cost Of Revenue $698.8M $245.5M
YoY Change 184.64% -0.63%
Gross Profit $63.13M $7.607M
YoY Change 729.87% -45.06%
Gross Profit Margin 8.29% 3.01%
Selling, General & Admin $123.9M $47.91M
YoY Change 158.6% 9.66%
% of Gross Profit 196.26% 629.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.118M $1.090M
YoY Change 186.06% -30.13%
% of Gross Profit 4.94% 14.33%
Operating Expenses $123.9M $47.91M
YoY Change 158.6% 9.66%
Operating Profit -$63.83M -$41.39M
YoY Change 54.22% 32.02%
Interest Expense $3.880M $1.297M
YoY Change 199.15% -61.72%
% of Operating Profit
Other Income/Expense, Net $33.00K $53.00K
YoY Change -37.74% 341.67%
Pretax Income -$65.61M -$63.18M
YoY Change 3.86% 89.33%
Income Tax $194.0K $52.00K
% Of Pretax Income
Net Earnings -$65.81M -$63.23M
YoY Change 4.08% 89.65%
Net Earnings / Revenue -8.64% -24.98%
Basic Earnings Per Share
Diluted Earnings Per Share -$482.1K -$2.000M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.464B $651.0M
YoY Change 124.82%
Cash & Equivalents $1.501B $651.0M
Short-Term Investments
Other Short-Term Assets $87.10M $39.70M
YoY Change 119.4%
Inventory $520.0M $141.1M
Prepaid Expenses
Receivables $100.5M $15.29M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.171B $847.0M
YoY Change 156.32%
LONG-TERM ASSETS
Property, Plant & Equipment $21.40M $9.783M
YoY Change 118.72%
Goodwill $159.3M $78.17M
YoY Change 103.79%
Intangibles $297.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $19.81M $12.47M
YoY Change 58.83%
Total Long-Term Assets $249.5M $116.2M
YoY Change 114.8%
TOTAL ASSETS
Total Short-Term Assets $2.171B $847.0M
Total Long-Term Assets $249.5M $116.2M
Total Assets $2.421B $963.2M
YoY Change 151.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $69.81M $20.13M
YoY Change 246.76%
Accrued Expenses $86.33M $40.90M
YoY Change 111.08%
Deferred Revenue $15.49M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $363.6M $109.8M
YoY Change 231.16%
Total Short-Term Liabilities $659.0M $204.1M
YoY Change 222.95%
LONG-TERM LIABILITIES
Long-Term Debt $609.0M $0.00
YoY Change
Other Long-Term Liabilities $3.584M $1.965M
YoY Change 82.39%
Total Long-Term Liabilities $3.584M $1.965M
YoY Change 82.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $659.0M $204.1M
Total Long-Term Liabilities $3.584M $1.965M
Total Liabilities $1.284B $217.8M
YoY Change 489.56%
SHAREHOLDERS EQUITY
Retained Earnings -$920.9M -$679.4M
YoY Change 35.55%
Common Stock $2.057B $1.425B
YoY Change 44.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.137B $745.4M
YoY Change
Total Liabilities & Shareholders Equity $2.421B $963.2M
YoY Change 151.31%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$65.81M -$63.23M
YoY Change 4.08% 89.65%
Depreciation, Depletion And Amortization $3.118M $1.090M
YoY Change 186.06% -30.13%
Cash From Operating Activities -$181.4M $25.15M
YoY Change -821.28% -127.95%
INVESTING ACTIVITIES
Capital Expenditures -$5.703M -$1.430M
YoY Change 298.81% 169.81%
Acquisitions
YoY Change
Other Investing Activities $5.000K
YoY Change
Cash From Investing Activities -$5.708M -$1.430M
YoY Change 299.16% 169.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 721.0M 446.8M
YoY Change 61.35% 755.18%
NET CHANGE
Cash From Operating Activities -181.4M 25.15M
Cash From Investing Activities -5.708M -1.430M
Cash From Financing Activities 721.0M 446.8M
Net Change In Cash 533.9M 470.6M
YoY Change 13.45% -1329.87%
FREE CASH FLOW
Cash From Operating Activities -$181.4M $25.15M
Capital Expenditures -$5.703M -$1.430M
Free Cash Flow -$175.7M $26.58M
YoY Change -761.02% -129.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134043969
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134043969
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
132000
CY2021Q2 us-gaap Senior Long Term Notes
SeniorLongTermNotes
608960000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12093000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2151000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2803000
CY2020Q4 us-gaap Liabilities
Liabilities
496954000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2004841000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-777871000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1227102000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1724056000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761890000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253093000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
698762000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2057479000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6612000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12348000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17137000
CY2021Q2 us-gaap Liabilities
Liabilities
1283893000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3584000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-920867000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1136746000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2420639000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136717347
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
136717347
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
350000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
105000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-65807000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-63228000
us-gaap Net Income Loss
NetIncomeLoss
-142996000
us-gaap Net Income Loss
NetIncomeLoss
-104287000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.00
us-gaap Gross Profit
GrossProfit
25994000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
232764000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106291000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1083000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5900000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2049000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-63828000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-41387000
us-gaap Operating Income Loss
OperatingIncomeLoss
-139360000
us-gaap Operating Income Loss
OperatingIncomeLoss
-82346000
CY2021Q2 us-gaap Interest Expense
InterestExpense
3880000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1297000
us-gaap Interest Expense
InterestExpense
7692000
us-gaap Interest Expense
InterestExpense
4123000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2062000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
715000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4358000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2671000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21260000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65613000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63176000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142646000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-104182000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
194000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.21
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
136507177
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31599497
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
136002344
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20035476
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-573852000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
600000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1818000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-41059000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3948000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1285000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-616123000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
36507000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
745435000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2127000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
901046000
CY2020Q2 vrm Stock Issued During Period Value Conversion Of Redeemable Convertible Preferred Stock Warrant To Common Stock Warrant
StockIssuedDuringPeriodValueConversionOfRedeemableConvertiblePreferredStockWarrantToCommonStockWarrant
21873000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4100000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000
CY2020Q2 vrm Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
1000
CY2020Q2 vrm Stock Issued During Period Value Withheld To Satisfy Employee Tax Withholding Obligations
StockIssuedDuringPeriodValueWithheldToSatisfyEmployeeTaxWithholdingObligations
878000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-63228000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1227102000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
39030000
CY2021Q1 vrm Adjustments To Additional Paid In Capital Fair Value Of Unvested Stock Options Assumed For Acquisition
AdjustmentsToAdditionalPaidInCapitalFairValueOfUnvestedStockOptionsAssumedForAcquisition
1017000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2820000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2821000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-77189000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1195601000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5392000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1560000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-65807000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1136746000
us-gaap Profit Loss
ProfitLoss
-142996000
us-gaap Profit Loss
ProfitLoss
-104287000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6028000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2059000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
698000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
375000
us-gaap Share Based Compensation
ShareBasedCompensation
8212000
us-gaap Share Based Compensation
ShareBasedCompensation
4700000
us-gaap Inventory Write Down
InventoryWriteDown
3093000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2818000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41393000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
99412000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-66247000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
26669000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7909000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
919000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26306000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4714000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16788000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1835000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
62117000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1905000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-151851000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8943000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3128000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
76145000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-85088000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3128000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
420000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
611000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1070110000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
465663000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1035727000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
529341000
vrm Payment Of Vehicle Floor Plan Upfront Commitment Fees
PaymentOfVehicleFloorPlanUpfrontCommitmentFees
1125000
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
625000000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
16175000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
21694000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1818000
vrm Common Stock Shares Withheld To Satisfy Employee Tax Withholding Obligations
CommonStockSharesWithheldToSatisfyEmployeeTaxWithholdingObligations
878000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
504023000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1740000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4381000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-66000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
647589000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
456425000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
410650000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
453301000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1090039000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
219587000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1500689000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
672888000
us-gaap Interest Paid Net
InterestPaidNet
6713000
us-gaap Interest Paid Net
InterestPaidNet
2743000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
269000
vrm Issuance Of Common Stock For Acquisition Of Business
IssuanceOfCommonStockForAcquisitionOfBusiness
39030000
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1017000
vrm Conversion Of Redeemable Convertible Preferred Stock Warrant To Common Stock Warrant
ConversionOfRedeemableConvertiblePreferredStockWarrantToCommonStockWarrant
21873000
vrm Issuance Of Common Stock As Upfront Payment To Nonemployee
IssuanceOfCommonStockAsUpfrontPaymentToNonemployee
2127000
CY2020Q2 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
2-for-1
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q4 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
11500000
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10800000
CY2020Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
54.50
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569500000
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, revenue, and expenses and related disclosures. On an ongoing basis, the Company evaluates its estimates, including, among others, those related to income taxes, the realizability of inventory, stock-based compensation, contingencies, revenue-related reserves, fair value measurements, goodwill, and useful lives of property and equipment and intangible assets. The Company bases its estimates on historical experience, market conditions, and on various other assumptions that are believed to be reasonable. Actual results may differ from these estimates. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.78%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to the evolving and uncertain nature of the COVID-19 pandemic, it is reasonably possible that it could materially impact the Company’s estimates, particularly those noted above that require consideration of forecasted financial information, in the near to medium term. The ultimate impact will depend on numerous evolving factors that the Company may not be able to accurately predict, including the duration and extent of the pandemic, the impact of federal, state, local and foreign governmental actions, consumer behavior in response to the pandemic and other economic and operational conditions the Company may face.</p>
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-bottom:0pt;margin-top:8pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Significant Customers</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents and accounts receivable, which are unsecured. The Company’s cash balances are maintained at various large financial institutions. Deposits held with financial institutions may at times exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, management believes they bear minimal risk. The Company’s cash equivalents primarily consist of money market funds that hold investments in highly liquid US treasury securities. Concentration of credit risk with respect to accounts receivable is generally mitigated by a large customer base. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:6.78%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:2pt;text-indent:6.78%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three and six months ended June 30, 2021 and 2020, no customer represented 10% or more of the Company’s revenues and no customer represented more than 10% of the Company’s accounts receivable as of June 30, 2021 and December 31, 2020. </p>
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
569500000
CY2020Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1500000
CY2020Q4 vrm Reserve For Chargebacks
ReserveForChargebacks
3800000
CY2021Q2 vrm Cumulative Profit Sharing Payment Recognized
CumulativeProfitSharingPaymentRecognized
15100000
CY2021Q2 vrm Reserve For Chargebacks
ReserveForChargebacks
6900000
CY2021Q2 vrm Vehicles
Vehicles
518331000
CY2020Q4 vrm Vehicles
Vehicles
421458000
CY2021Q2 vrm Parts And Accessories
PartsAndAccessories
1635000
CY2020Q4 vrm Parts And Accessories
PartsAndAccessories
2189000
CY2021Q2 us-gaap Inventory Net
InventoryNet
519966000
CY2020Q4 us-gaap Inventory Net
InventoryNet
423647000
CY2021Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
16000000.0
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
12900000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
37742000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28426000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16345000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13334000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21397000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15092000
CY2019Q4 us-gaap Goodwill
Goodwill
78172000
CY2020Q2 us-gaap Goodwill
Goodwill
78172000
CY2020Q4 us-gaap Goodwill
Goodwill
78172000
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
81134000
CY2021Q2 us-gaap Goodwill
Goodwill
159306000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34592000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
292000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3274000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
258000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31318000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000.0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
300000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
3111000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6220000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6215000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6215000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6215000
CY2021Q2 vrm Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
3342000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
31318000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4890000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11655000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
11155000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
86328000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
59405000
CY2021Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
12168000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9106000
CY2021Q2 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
23023000
CY2020Q4 vrm Accrued Vehicle Related Expenses Current
AccruedVehicleRelatedExpensesCurrent
13062000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
28409000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
15443000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7242000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5749000
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3831000
CY2021Q2 vrm Vehicle Payable Current
VehiclePayableCurrent
68737000
CY2020Q4 vrm Vehicle Payable Current
VehiclePayableCurrent
25086000
CY2021Q2 vrm Other Current
OtherCurrent
22249000
CY2020Q4 vrm Other Current
OtherCurrent
5189000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
90986000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30275000
CY2020Q2 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
85533394
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On June 11, 2020, the Company amended its certificate of incorporation to effect a 2-for-1 forward stock split of shares of the Company’s outstanding common stock, such that each share of common stock, $0.001 par value became two shares of common stock, $0.001 par value per share.
CY2020Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3
CY2021Q2 vrm Segment Assets
SegmentAssets
0
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761890000
CY2021Q2 us-gaap Gross Profit
GrossProfit
63128000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253093000
CY2020Q2 us-gaap Gross Profit
GrossProfit
7607000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1353008000
us-gaap Gross Profit
GrossProfit
99304000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
628865000
us-gaap Gross Profit
GrossProfit
25994000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
761890000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
253093000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1353008000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
628865000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
123898000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47911000
us-gaap Interest Expense
InterestExpense
4123000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
232764000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106291000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3058000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1083000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5900000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2049000
CY2021Q2 us-gaap Interest Expense
InterestExpense
3880000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1297000
us-gaap Interest Expense
InterestExpense
7692000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2062000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
715000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4358000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2671000
CY2020Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
21260000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
20470000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
33000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
48000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
86000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65613000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-63176000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142646000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-104182000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0030
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0008
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0025
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0010
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17890177
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12077860
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-65807000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-63228000
us-gaap Net Income Loss
NetIncomeLoss
-142996000
us-gaap Net Income Loss
NetIncomeLoss
-104287000
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
136507177
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31599497
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
136002344
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20035476
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.48
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.05
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.21

Files In Submission

Name View Source Status
0001564590-21-043465-index-headers.html Edgar Link pending
0001564590-21-043465-index.html Edgar Link pending
0001564590-21-043465.txt Edgar Link pending
0001564590-21-043465-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gzgszjgonr12000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vrm-10q_20210630.htm Edgar Link pending
vrm-10q_20210630_htm.xml Edgar Link completed
vrm-20210630.xsd Edgar Link pending
vrm-20210630_cal.xml Edgar Link unprocessable
vrm-20210630_def.xml Edgar Link unprocessable
vrm-20210630_lab.xml Edgar Link unprocessable
vrm-20210630_pre.xml Edgar Link unprocessable
vrm-ex101_353.htm Edgar Link pending
vrm-ex311_8.htm Edgar Link pending
vrm-ex312_9.htm Edgar Link pending
vrm-ex321_6.htm Edgar Link pending
vrm-ex322_7.htm Edgar Link pending